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Aquaporins (AQPs) are intrinsic membrane proteins that facilitate selective water and small solute movement across the plasma
membrane. In this study, we investigate the role of inhibiting AQPs in sensitising prostate cancer cells to cryotherapy. PC-3 and DU145
prostate cancer cells were cooled to 0,  5 and  101C. The expression of AQP3 in response to freezing was determined using real-
time quantitative polymerase chain reaction (RT–qPCR) and western blot analysis. Aquaporins were inhibited using mercuric
chloride (HgCl2) and small interfering RNA (siRNA) duplex, and cell survival was assessed using a colorimetric assay. There was a
significant increase in AQP3 expression in response to freezing. Cells treated with AQP3 siRNA were more sensitive to cryoinjury
compared with control cells (Po0.001). Inhibition of the AQPs by HgCl2 also increased the sensitivity of both cell lines to cryoinjury
and there was a complete loss of cell viability at  101C( Po0.01). In conclusion, we have shown that AQP3 is involved directly in
cryoinjury. Inhibition of AQP3 increases the sensitivity of prostate cancer cells to freezing. This strategy may be exploited in the clinic
to improve the efficacy of prostate cryotherapy.
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Prostate cancer is recognised as one of the most common non-
dermatological male cancers in the United Kingdom, accounting
for almost one in four of all new male cancers (Cancer research
UK, 2007). It represents the second most common cause of cancer
death (Jemal et al, 2007). Radical prostatectomy and external beam
radiotherapy remain the two main active treatment modalities for
prostate cancer with acceptable results, although they may be
associated with varying degrees of morbidity (Lim et al, 1995;
Kupelian et al, 1997; Aus et al, 2005). Prostate cryotherapy is the
localised application of a freezing temperature resulting in
in situ tissue ablation. Presently, cryotherapy represents a
minimally invasive alternative treatment for localised or locally
advanced prostate cancer. Clinical case series studies confirmed
the feasibility of cryotherapy as a primary and salvage treatment
for patients with localised or locally advanced prostate cancer
(Ismail et al, 2007; Cohen et al, 2008).
The aim of prostate cryotherapy is to selectively destroy
neoplastic tissue and preserve vital structures around the prostate,
such as rectum and urinary bladder, and a precise freezing process
is required to achieve this goal. The targeted tissue has to be
exposed to a temperature lower than  401C to ensure a complete
eradication of the cancer tissue (Larson et al, 2000). It is
technically challenging to achieve the lethal critical temperature
in all the prostatic tissues, especially at the periphery of the ice ball,
as this will result in a high percentage of complications. Therefore,
complete ablation of prostate cancer tissue often fails and results
in local disease recurrence.
Cold injury starts when temperature falls to subzero levels and
extracellular ice starts to form at a temperature range between  7
and  201C. Ice formation will create a hyperosmolar extracellular
environment and expose cells to osmotic stress. Lower tempera-
tures (o 151C) are associated with intracellular ice formation,
which is almost always lethal to the cells (Gage and Baust, 1998).
The aquaporin (AQP) family of water channels are intrinsic
membrane proteins that facilitate selective water and small solute
movement across the plasma membrane (Verkman and Mitra,
2000). They were initially characterised in human red blood and
renal cells (Preston et al, 1992; Nielsen et al, 1993). Subsequently,
they were identified in mammals, plants, yeasts and arthropods. To
date, 13 members of the AQP family have been identified in
mammals (AQP0–12). Mammalian AQPs were stratified into two
subgroups. Members of the first subgroup, including AQP1, AQP2,
AQP4, AQP5, AQP6 and AQP8, are highly selective for the passage
of water across the plasma membrane. The second group is the
aquaglyceroporins, which includes AQP3, AQP7, AQP9 and AQP10;
they permit the transport of small non-ionic molecules, such as
glycerol, in addition to water (Ishibashi et al, 1994).
Only recently, the role of AQP in tumour pathogenesis has been
identified. Aquaporin 3 was found to be expressed in normal and
malignant prostate tissue and may be involved in tumour initiation
and development (Wang et al, 2007). The expression of AQP1 is
confined to the capillary endothelium of prostate cancer cells and
it may be involved in microvascular alteration during tumour
angiogenesis (Mobasheri et al, 2005). There has been increasing
evidence that AQPs may play a role in carcinogenesis. The
oncogenic properties of AQP5 in lung and colorectal cancer were
examined recently (Woo et al, 2008). It was shown that AQP5
phosphorylation at the PKA substrate consensus site plays a key Received 2 April 2009; revised 20 April 2009; accepted 28 April 2009
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srole in cell proliferation. A recent study by the same group showed
that AQP5 expression in colorectal cancer is significantly
associated with lung metastasis that is possibly mediated by the
activation of Ras, mitogen activated protein kinase (MAPK) and
Rb signalling pathways (Kang et al, 2008).
In this study, we investigate the effects of inhibiting the AQP in
sensitising human prostate cancer cells to cryotherapy using an
in vitro model. The expression of the AQP by PC-3 and DU145 cells
before and after cryoinjury was determined using qPCR. We have
assessed the potential use of RNA interference (RNAi) technology
as an adjunctive therapy to cryotherapy to enhance anti-tumour
efficacy. To our knowledge, this is the first study that evaluates the
role of AQPs in the tolerance of human prostate cancer cells to
cryoinjury.
MATERIALS AND METHODS
Prostate cancer cell culture
The human DU145 and PC-3 cell lines were obtained from the
ATCC (American Type Culture Collection). Cells were grown in
a complete culture medium (RPMI 1640 with 10% foetal calf
serum, 1% L-glutamine and 1% penicillin/streptomycin, all from
Sigma-Aldrich, Poole, UK) and incubated at 371C with 5% CO2.
Cells were suspended in 5ml of fresh culture medium. A final cell
density of 1 10
5 cells per ml were placed in 1.5ml Eppendorf
tubes and centrifuged at 600r.p.m. for 1min.
Freezing protocol
Cells were treated using the Cryocare system (Endocare Inc.,
Irvine, CA, USA). Briefly, Eppendorf tubes containing prostate
cancer cells were placed 6mm from the centre of a single
cryoprobe and held in place by a temperature probe to monitor
the sample temperature. The cells were cooled to 0,  5 and  101C
for 10min, and then thawed in a 501C water bath to room
temperature. The apparatus allows cells to be treated at a range of
temperatures between 0 and  401C and to be held reproducibly at
specific temperatures for as long as required.
Inhibition of AQPs by HgCl2
Prostate cancer cells were treated with the AQP inhibitor, mercuric
chloride (HgCl2) (Sigma-Aldrich), at a concentration of 0.075mM
for 15min. Cells were washed twice and cooled to  101C for
10min. Cell survival was compared with the untreated cells, cells
cooled in the absence of HgCl2 and cells treated with HgCl2
only using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay
(Promega, Madison, WI, USA).
Small interfering RNA (siRNA) synthesis
RNA duplex of 19 nucleotides specific for human AQP3 sequence
was synthesised by Thermo Scientific Dharmacon (Lafayette, CO,
USA). ON-TARGETplus siRNA (Dharmacon, Lafayette, CO, USA)
smart pool is a mixture of four siRNAs targeting AQP3, which
attains the maximum target gene silencing and reduces the overall
number of off-target interactions. ON-TARGETplus negative
control, which has minimal targeting of known genes in the
human genome, was used as a control siRNA.
Target sequence GGAUCAAGCUGCCCAUCUA
(Sense orientation) CUUCUUGGGUGCUGGAAUA
UAUGAUCAAUGGCUUCUUU
GAGCAGAUCUGAGUGGGCA
Transfection of human prostate cancer cells with siRNA
DU145 and PC-3 cells were diluted in an antibiotic-free complete
medium to a plating density of 1.0 10
5 cells per ml and 500mlo f
cells were seeded in each well of a 24-well plate. Cells were
incubated at 371C with 5% CO2 overnight. Small interfering RNA
transfection was carried out using the DharmaFECT 2 transfection
reagent (Dharmacon) following the manufacturer’s protocol.
A stock solution of 2mM of the AQP3 siRNA was prepared,
aliquoted and stored at  201C. Aquaporin 3 siRNA was diluted in
a ratio of 1:1 in a serum-free RPMI medium. In parallel, 3mlo f
the DharmaFECT 2 reagent was added to 197ml of serum-free
medium. The two mixtures were combined and incubated for
20min at room temperature for complex formation. After the
addition of a sufficient antibiotic-free complete medium (final
concentration of AQP3 siRNA is 100nM), 500ml of the mixture
was added to each well and cells incubated at 371C with 5% CO2.
Control siRNA was prepared in a similar way to AQP3
siRNA. Mock-transfected cells are cells that were treated with
DharmaFECT 2 reagent only. Cell survival was assessed at day 6
and compared with the untreated cells. Cells were harvested at
day 3 for mRNA analysis and at day 6 post transfection for
protein analysis.
Cell treatment after siRNA transfection
AQP3-specific gene silencing was confirmed by three independent
western blot and q-PCR experiments. Untreated cells, cells treated
with control siRNA and mock-transfected cells were used as
controls. Transfected cells were harvested and treated with freezing
at  101C as described above. Cell survival was assessed using the
MTS assay and compared with the control cells and cells treated at
 101C without transfection.
Real-time quantitative polymerase chain reaction
(RT–qPCR)
Real-time quantitative polymerase chain reaction analysis was per-
formed using the Stratagene Mx3005P qPCR system (Stratagene,
La Jolla, CA, USA). Glyceraldehyde 3-phosphate dehydrogenase
was used as a reference gene and all reactions were performed in
duplicate in a 96-well plate. A volume of 25ml of PCR reaction
mixture contained 1ml cDNA, 1ml of each AQP primer, 10.5ml
nuclease-free water and 12.5ml SYBR Green JumpStart Taq
ReadyMix (Sigma-Aldrich). Primers were designed using the
Primer3 software (http://frodo.wi.mit.edu/) and obtained from
the Eurogentec group (Eurogentec Ltd, Southampton, Hampshire,
UK). The efficiency of RT–qPCR was calculated using a standard
curve. Thermal cycling conditions were as follows: 1 cycle (10min
at 951C) followed by 40 cycles (30s at 951C, 1min at 601C and 30s
at 721C) followed by 1 cycle (1min 951C, 30s at 551C and 30s at
951C). The 2
 DDCT method was used to calculate the difference in
CT value between the treated sample and untreated control and is
expressed as a fold change in gene expression relative to the
untreated cells. Results were then normalised to an endogenous
reference gene (GAPDH) whose expression is constant in all
groups.
DDCT¼(CT,Target CTReference gene)treated–(CT,Target CTReference
gene)untreated.
Western blot analysis
After treatment, cells were washed with phosphate-buffered saline
(PBS) and lysed with RIPA (RadioImmuno Precipitation Assay)
Buffer containing protease and phosphatase inhibitor cocktail and
EDTA (ethylenediaminetetraacetic acid) (all from Perbio Science,
Cramlington, Northumberland, UK). The cells were then centri-
fuged at 13000r.p.m. for 5min and the supernatant collected and
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sstored at  201C. Protein concentration was determined using the
BCA protein assay kit (Perbio Science) as per the manufacturer’s
instructions. A total of 25mg of protein was added to 2.5mlo f
sample buffer and 1ml of reducing agent and incubated at 701C for
10min and was then loaded on a Bis Tris gel (all from Invitrogen,
Paisley, UK). Proteins were transferred from within the gel onto a
PVDF membrane and blocked with 50ml of blocking buffer (PBS,
0.1% Tween 20 and 5% Bovine serumalbumin). The membrane
was incubated with the primary antibody against AQP3 (1:1000)
(Santa Cruz, Santa Cruz, CA, USA) and b-actin (1:5000) (Abcam,
Cambridge, UK) overnight at 41C. The membrane was then
incubated with a secondary antibody (peroxidase-labelled anti-
goat antibody) and detected using the enhanced chemiluminescent
detection method (GE Healthcare, Buckinghamshire, UK).
Immunofluorescence staining
PC-3 and DU145 cells were cooled to  101C according to freezing
protocol and recovered for 24h in a 371Ca n d5 %C O 2 incubator.
Cells were washed in PBS, fixed with 10% formalin for 10min and
blocked with the blocking buffer at room temperature for 30min.
The cells were then incubated with the primary antibody against
AQP3 (1:200 dilution) overnight at 41C. After washing, the cells were
incubated with the secondary Ab (Donkey anti-goat IgG antibody,
Alexa Fluor 488 Conjugated, Invitrogen) at room temperature for 1h.
Negative control included cells incubated with the dilution buffer
without the addition of a primary antibody to determine the levels of
non-specific fluorescence. Immunofluorescence was visualised using
Eclipse TE2000-S microscope (Nikon, Japan).
RESULTS
Cryotherapy results in increased expression of AQP3 in
prostate cancer cells
Prostate cancer cells were cooled to 0,  5 and  101C for 10min.
After overnight recovery, total RNA and protein were extracted
and AQP1, AQP3 and AQP9 mRNA expression was assessed using
q-PCR. The AQP3 expression in the untreated cells was compared
with GAPDH mRNA expression. Untreated DU145 cells expressed
significant levels of AQP3, which is six-fold more than the
expression of GAPDH (Figure 1A). Untreated PC-3 cells expressed
lower levels of AQP3 (Figure 1B). There was an overall increase in
the expression of AQP3 in DU145 and PC-3 cells on exposure to
 101C freezing temperature. In DU145 cells, the AQP3 expression
slightly reduced at 0 and  51C( P40.05) followed by a significant
increase in expression at  101C( Po0.001; Figure 2). PC-3 cells
showed a similar trend to DU145 cells, with a significant increase
in the AQP3 expression at  101C compared with the untreated
cells (data not shown). The AQP1 mRNA expression significantly
increased in cells cooled to  5 and  101C( Po0.01). The AQP9
mRNA levels did not change significantly after exposure to
cryoinjury. The AQP3 protein and mRNA expression was
evaluated 2, 8 and 24h post freezing at  101C using RT–qPCR
and western blot analysis. The results show that in the immediate
post-freeze period, there are 5- and 50-fold increases in AQP3
expression in DU145 and PC-3 cells, respectively, followed by a
gradual return to the untreated level (Figure 3). This response may
represent an important adaptive mechanism used by the cells to
face the osmotic stress associated with cryoinjury.
Inhibition of AQPs by mercuric chloride increases the
sensitivity of prostate cancer cells to freeze injury
Mercuric chloride is an inhibitor of the AQP, which has been used
routinely to test AQP function in animal and plants cells. It has a
high affinity to the reactive thiol moiety of cysteine residues within
the AQPs, causing covalent changes leading to the inhibition of
water transport function (Savage and Stroud, 2007). To ascertain
the effect of HgCl2 on prostate cancer cell survival, DU145 and
PC-3 cells were treated with various concentrations of HgCl2 for
15min, and survival was assessed using the MTS assay. PC-3 cells
were very sensitive to HgCl2 treatment and more than 80% died at
low concentration (0.075mM). DU145 cells were more resistant to
HgCl2 and the IC50 was 0.15mM (Figure 4). DU145 cells were
treated with 0.078mM of HgCl2 for 15min, and the cells were then
cooled to  101C for 10min. Cell survival was assessed using the
MTS assay and compared with the untreated cells, cells treated
with HgCl2 or freezing alone. Mercuric chloride or cryotherapy
treatment alone resulted in a 40 and 80% reduction in cell survival,
respectively. The combination treatment resulted in a significant
reduction in cell survival compared with either treatment alone,
with almost a complete loss of cell viability after treatment
(Po0.001; Figure 5). To determine whether the combination
treatment is synergistic, the combination index (CI) was calculated
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Figure 1 AQP1, AQP3 and AQP9 mRNA expression in (A) DU145 and
(B) PC-3 human prostate cancer cells. RNA was extracted from fresh cells,
reverse-transcribed, and expression levels were calculated as a fold change
relative to GAPDH expression.
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Figure 2 The expression of AQP1, AQP3 and AQP9 in DU145 cells in
response to freezing. Cells were cooled to 0,  5 and  101C for 10min
and thawed to room temperature. RNA was extracted, reverse-
transcribed, and mRNA expression was measured as a fold change relative
to the untreated cells. The expressions of AQP1 and AQP3 mRNA were
significantly increased at  101C( Po0.001).
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susing CalcuSyn software (Biosoft, Cambridge, UK) that uses the
median effect principle. The CI provides a quantitative measure of
the degree of interaction between two or more agents (Chou and
Talalay, 1984). The CI for the combination treatment was 0.2,
which denotes a marked synergy between the two treatments.
AQP3 inhibition by siRNA in prostate cancer cells
To further investigate the role of specific AQPs in protecting
prostate cancer cells from cryoinjury, an AQP3 silencing experi-
ment was carried out with 100nM of AQP3 siRNA. Aquaporin 3
gene silencing was monitored by RT–qPCR at day 3 and western
blot analysis at day 6 after inducing RNAi. A control siRNA was
used in parallel to test for the potential non-specific effects of the
short RNA duplex. To evaluate the toxic effect of transfection on
overall viability, cell survival was assessed using the MTS assay at
day 6 after the addition of the siRNA. The percentage of cell
survival was above 80% in all groups indicating optimal
transfection conditions with no toxic effect of the lipid complex
on the treated cells (P40.05; data not shown). The results show
that AQP3 mRNA levels were significantly decreased 3 days after
the treatment with siRNA to o10% of the control. There was no
significant change in the AQP3 mRNA expression in cells treated
with control siRNA and mock-transfected cells. Western blot
analysis showed a reduction in AQP3 protein levels at day 6,
whereas protein expression levels were unaffected in cells treated
with control siRNA and in mock-transfected cells showing the
specificity of the results (Figure 6).
Assessment of cell survival in AQP3 knockdown cells
compared with normal cells
The AQP inhibitor (HgCl2) resulted in a significant decrease in
DU145 cell viability after exposure to  101C. To further investigate
the specificity of AQP3 inhibition in increasing cell sensitivity to
cryotherapy, different cell groups were cooled to  101C and cell
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Figure 3 AQP3 expression by RT–qPCR and western blot analysis in (A) DU145 and (B) PC-3 cells over time intervals post freezing. There was a
significant increase in AQP3 expression 2h after freezing followed by a time-dependent reduction to the control levels.
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Figure 4 The effect of mercuric chloride (HgCl2) on DU145 and PC-3
cell survival. Cells were grown in a 96-well plate and treated with various
concentrations of HgCl2 in a fresh culture medium for 15min. Cell survival
was assessed using the MTS assay. DU145 cells were more resistant to
HgCl2 than PC-3 cells.
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Figure 5 (A) DU145 and (B) PC-3 cells after exposure to 0.075mM
mercuric chloride (HgCl2), freezing (Cryo ( 10)) and combination of
HgCl2 and freezing (Combo). Survival was measured as a percentage of the
untreated cells. There was a complete loss of DU145 cell survival at  101C
(Po0.001).
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sviability was assessed using the MTS assay. Four groups were
compared, namely fresh cells (cryo  10), cells transfected with
AQP3 siRNA (AQP3 siRNA), cells transfected with control siRNA
(control siRNA) and mock-transfected cells (mock transfection).
Cell survival was assessed as a percentage relative to the untreated
cells. The results show a statistically significant increase in cell
death after exposure to cryoinjury in AQP3 knockdown cells
compared with fresh cells (Po0.001; Figure 7). Cells treated with
control siRNA and mock-transfected cells showed a similar cell
viability to fresh cells after exposure to freezing (P40.05). We
showed clearly that increased sensitivity to cryoinjury was specific
to AQP3 knockdown in DU145 and PC-3 cells indicating that the
AQP3 gene product may play a role in protecting prostate cancer
cells from cryoinjury.
Cryotherapy results in relocalisation of AQP3 into the
plasma membrane
It was shown that AQP3 protein is expressed in the cytoplasm of
the human prostate cancer cells (Wang et al, 2007). Transporter
proteins need to be expressed in the plasma membrane to
function. In this study, we investigated the expression and
localisation of AQP3 in prostate cancer cells in response to
cryoinjury using immunofluorescence staining. Cryotherapy
markedly redistributed AQP3 protein into the plasma membrane
of prostate cancer cells. Figure 8 clearly shows membrane
expression of AQP3 in PC-3 cells. DU145 cells showed a similar
finding (data not shown). Control wells incubated with dilution
buffer showed no immunoreactivity (data not shown).
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Figure 6 AQP3 mRNA and protein levels in (A) DU145 and (B) PC-3 cells were assessed by RT–qPCR and western blot analysis 3 and 6 days after
AQP3 transfection, respectively. Multiple controls were used to verify the specificity of the treatment.
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Figure 7 (A) DU145 and (B) PC-3 cell after exposure to cryoinjury.
AQP3 knockdown cells showed a significant reduction in cell viability after
exposure to cryoinjury compared with the other groups (Po0.001). Cell
survival is expressed as a percentage of the untreated cells.
Figure 8 Immunofluorescence expression and localisation of AQP3 post
cryotherapy. It is clear that AQP3 is expressed on the plasma membrane of
PC-3 cells. A similar finding was observed in DU145 cells. Original
magnification  600.
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sDISCUSSION
Cryotherapy is an effective therapy for localised or locally
advanced prostate cancer (Ismail et al, 2007). Clinical reports
indicate that  401C represents the ideal target temperature for a
satisfactory prostate tissue ablation (Larson et al, 2000). As this is
not achieved clinically, a complete ablation of cancer tissue some
times fails and results in disease recurrence. Therefore, a second
synergistic therapy is of great potential benefit. Some synergistic
cell killing has been achieved with concomitant cryotherapy and
chemotherapy, radiotherapy, hyperthermia and apoptosis indu-
cing ligands (Robilotto et al, 2007).
In this study, we identified inhibition of AQPs as a further
therapeutic target that may be synergistic with cryotherapy. During
the initial phase of freezing, ice formation starts in the extracellular
space creating a hyperosmolar environment and leading to water
escape from the intracellular to the extracellular space along the
osmotic gradient. Intracellular hyperosmolarity will result in a
reduction in the critical temperature of intracellular ice formation.
Inhibiting the AQPs, which are primarily responsible for controlling
water transport across the plasma membrane, will lead to
intracellular water retention and to a subsequent increase in the
critical temperature at which intracellular ice will form.
In this study, we provide strong evidence that AQP protein can
play a key role in modulating prostate cancer cell response to
cryotherapy. Aquaporin 3 was expressed in both prostate cancer
cell lines and it was used as a target in this study. Exposure to
freezing temperature provided a strong stimulus for enhanced
expression of AQP3 in an attempt to overcome the osmotic stress.
Similar upregulation on exposure to mild hypothermia was
reported in earlier studies (Fujita et al, 2003). Cryotherapy
increases the expression of AQP3 through two mechanisms. First,
by creating a hyperosmolar environment at the extracellular space
that leads to increased expression of AQP3 (Bell et al, 2009).
Second, we found a five-fold increase in MAPK14 expression in
prostate cancer cells on exposure to  101C freezing temperature
(unpublished data). Bell et al showed that MAPK14 is involved
directly in regulating AQP3 expression in response to hyperosmo-
tic stress. Therefore, the upregulation of AQP3 can be considered
as part of a protective physiological stress response to the osmotic
changes at the initial phase of cryoinjury. Aquaporin 3 is a
transporter protein that needs to be expressed in the cell
membrane to function. Wang et al showed that AQP3 is expressed
in the cytoplasm of prostate cancer cells. On the basis of our
finding from immunofluorescence staining, we showed clearly that
cryoinjury results in the relocalisation of AQP3 from the cytoplasm
to the plasma membrane, which may reflect the direct involvement
of AQP3 in the intracellular osmotic changes associated with
cryoinjury.
Earlier studies have reported on the relationship between AQP
water channels and freeze tolerance. Forced overexpression of
AQP3 in mouse oocytes increased survival after cryopreservation
in a glycerol-based medium (Edashige et al, 2003). Gene
expression analysis in baker’s yeast showed a correlation between
freeze resistance and the expression of AQP1 and AQP2 genes
(Tanghe et al, 2002). Deletion of the respective genes has raised the
sensitivity to cryoinjury. It was also shown that the high level of
freeze tolerance in arthropods was significantly reduced when the
expression of the AQP was inhibited by HgCl2 even in the presence
of glycerol as a cryoprotectant (Izumi et al, 2006; Philip et al,
2008).
On the basis of these observations, we examined the role of the
AQP in freeze tolerance of human prostate cancer cells. DU145
cells and PC-3 cells were frozen in the presence or absence of
mercuric chloride, a universal inhibitor of the AQPs (Niemietz and
Tyerman, 2002). We showed that cells exposed to combined
treatment were more seriously damaged by freezing at  101C
compared with cells exposed to cryotherapy alone. Inhibition of
the AQP interferes with water transport across the plasma
membrane down the osmotic gradient, which is essential for
maintaining the osmotic equilibrium and freeze tolerance (Philip
et al, 2008). Izumi et al (2006) suggested that freezing stress
requires control of water and solutes across the plasma membrane
and cell survival will depend on the portion of intracellular water
replaced by cryoprotectant. In this study, our aim was to increase
the efficacy of cryotherapy, therefore no cryoprotectant was used.
To further characterise the role of the AQP in freeze tolerance in
human prostate cancer cells, RNAi technology was used to knock
down AQP3 protein expression. We showed that although silencing
of AQP3 protein did not affect cell proliferation (data not shown),
it resulted in increased sensitivity of cancer cell to cryoinjury
compared with untreated cells. These data provide compelling
evidence that expression of the AQP on the plasma membrane is
essential for protecting human prostate cancer cells from
cryoinjury, suggesting a specific functional role of the AQP in
cancer cell biology. Thus, AQP inhibition by pharmacological
blockers might provide a new therapeutic approach for sensitising
human prostate cancer cells to cryotherapy.
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